Diarrhea outbreak in primate lab yields valuable Shigella vaccine insights
More than 150 non-human primates suffered a prolonged diarrhea outbreak, and researchers used the resulting immune data to identify new targets for a Shigella vaccine.
An extended outbreak of diarrhea struck more than 150 non-human primates in a research center, creating an unprecedented pool of immunological data. Researchers examined the specimens and identified specific Shigella molecules that the primates' immune systems targeted most effectively, linking these antigens to distinct protective antibody responses. They also detailed the exact micro-structures on those molecules where potent antibodies attach.
The study, published in Science Translational Medicine, highlights previously unknown aspects of natural anti-Shigella immunity and suggests pathways for rational vaccine design. Shigella infects over 200 million people annually and is increasingly resistant to antibiotics, underscoring the urgent need for a universal vaccine. This new molecular insight could accelerate development of candidates capable of protecting against multiple Shigella strains.
Why it matters
The research provides crucial molecular clues for creating a vaccine against a disease that kills hundreds of thousands each year.
In this story
